Intranasal as effective as IV naloxone

In this retrospective cohort of pre-hospital patients with suspected opiate overdose, the patients in the intranasal group and the intravenous group had about the same mean time to clinical response (20 vs 21 minutes). In patients with no IV access, intranasal naloxone is an effective alternative (abstract)

Danielle Scheurer

Dr. Scheurer is a clinical hospitalist and the Medical Director of Quality and Safety at the Medical University of South Carolina in Charleston, South Carolina, and is Assistant Professor of Medicine. She is a graduate of the University of Tennessee College of Medicine, completed her residency at Duke University, and completed her Masters in Clinical Research at the Medical University of South Carolina. She also serves as the Web Editor and Physician Advisor for the Society of Hospital Medicine.

Leave a Comment